Selank Where to Buy: Read the Scope, Not the Percentage

Selank where to buy is a documents question wearing the costume of a vendor question. No regulator has assessed a single batch of this peptide anywhere in the West, which means there is no marketing authorisation standing behind any vial, no pharmacopoeial monograph setting acceptance limits, and no inspection report to fall back on. What is left is the analytical file a seller is willing to publish, and whether that file is tied to the container that will arrive at your address.

That makes the assessment unusually tractable. Six tests decide it, all six can be scored from a browser, and none of them requires trusting a testimonial, a review score or the production quality of a storefront. The exercise below applies those six to the one vendor disclosed on this page, and it reports the two it fails as plainly as the four it passes.

Selank where to buy: the six tests, and what each one can settle

Each row below names a test, the question it answers, and the failure mode it catches. The right-hand column records what the February certificate for the lot discussed here actually contains, read on the review date.

Four passes, two absences. That is a better result than most of this market produces and it is not a clean sheet, and both halves of that sentence have to survive into whatever you decide.

The four the document does carry, and how to check them yourself

The identity test is the one a reader can reproduce with no equipment at all. Selank is a seven-residue peptide, Thr-Lys-Pro-Arg-Pro-Gly-Pro, an analogue of the immune peptide tuftsin extended at the C-terminus. Its entry in PubChem, CID 11765600, gives a molecular formula of C33H57N11O9, an average molecular weight of 751.9, and a monoisotopic mass of 751.434. The certificate states an expected monoisotopic mass of 751.43 Da and a measured value of 751.47 Da. Those two numbers were produced by different parties and they agree to 0.04 Da, roughly 53 parts per million, which is unremarkable for a routine liquid chromatography mass spectrometry instrument and entirely adequate for confirming the nominal mass of a peptide this size.

What makes it checkable rather than merely stated is that the certificate prints the spectrum. A doubly charged ion appears at m/z 376.734 and a singly charged ion at m/z 752.457, which is the pattern a 751 Da peptide produces under electrospray. A supplier quoting a mass with no spectrum behind it is asking to be believed. This is the same discipline our guide to reading a sequence, a salt form and a spectrum together applies to a different compound, and it transfers without modification.

The purity line is 99.32 percent by HPLC-UV, and the certificate publishes the peak list that produces it: two detected peaks, one at 7.13 minutes carrying 99.32 percent of the integrated area and one at 6.36 minutes carrying 0.68 percent. The detection window is 210.1 to 396.6 nm. Read carefully, that figure is an area-percent normalisation, which means it describes the proportion of what the detector saw, not the proportion of the powder by mass. The certificate says so itself, noting that salts and sugars used to aid solubility and buffer pH are not normally detected by UV and are not treated as impurities. Every serious purity number in this market carries that caveat, and the suppliers worth buying from are the ones that print it.

Quantity is the least common of the four and the most interesting. The certificate reports a measured quantity of 12.29 mg per vial against a 10 mg label. Publishing that number is a choice, because it can only ever be used against the seller: a lot that came in low would be equally visible. It is also lot-specific and should not be read as a standing overfill, a point we work through with the arithmetic in our piece on what a Selank listing has to declare.

The two absences, and why they are the two FDA named

Search the February certificate for endotoxin, LAL, pyrogen or sterility and you get nothing. There is no bacterial endotoxin result, no microbial screen, and no statement that either was attempted. That is not a hidden flaw; it is simply the scope of that document, which covers identity, purity and quantity and stops there. A later batch, discussed below, carries a wider panel, so the absence belongs to the lot rather than to the compound.

It matters because those two absences map onto the specific concern the regulator has put in writing about this substance. On its page covering bulk drug substances that may present significant safety risks, FDA states that compounded drugs containing selank acetate may pose risk for immunogenicity for certain routes of administration due to the potential for aggregation and peptide-related impurities, and that the agency lacks important information regarding any safety issues raised by selank acetate administered to humans. Aggregation and impurity burden are analytical questions. They are the reason the microbiological panel is not an optional extra for parenteral material, and why our companion piece on why sterility is not a purity figure keeps the two categories apart rather than letting a high purity number stand in for both.

The practical move is the same one we set out for a different compound in asking a supplier for the LAL result before ordering: name the test, name the lot, and ask in writing. A seller that has commissioned the work can forward a report in minutes. A seller that has not will change the subject to purity, which is the tell.

The comparison across batches, and the fair reading of it

The same vendor sells Semax, the other Russian nootropic heptapeptide, and its certificate for batch 30-05260628 is a different class of document. It carries a purity result of 99.886 percent against a stated specification of greater than 98 percent, a net content of 11.23 mg, an LC-MS identity confirmation, a heavy metals screen returning negative for arsenic, cadmium, lead and mercury, a bacterial endotoxin analysis run as a kinetic assay to USP Chapter 85 reporting below 0.20 EU/mL against an acceptance limit of 0.5 EU/mL across a 2.0 mL dilution volume, which is below 0.40 EU in total for the vial, and a rapid sterility screen reporting no growth of bacteria or fungi after two days at 30 to 35 degrees, a screen whose own report says full USP Chapter 71 testing may still be required. Two documents from one vendor, two very different evidence packages, and a reader can confirm every word of that in about a minute by opening every PDF on the page.

The uncharitable reading is that the vendor tests one product properly and the other casually. The evidence does not support it. The vendor’s earlier Semax certificate, lot 30-01260229 with an analysis date of 2026-02-09, carries no endotoxin or sterility result either, and it comes from the same laboratory and the same template as the Selank document from the same month. What changed between February and June was the testing package and the laboratory behind it, not the product. The vendor’s June Selank batch, 29-05260628, was certified by Kovera on 2 June 2026 with the same endotoxin, rapid sterility and heavy metals panel, thirteen days before the Semax batch above. The scope is set by the batch, not by the compound.

That reading is more useful to a buyer than the accusation would be, because it converts into a question with a real answer: which batch is in the vial that ships, and which certificate covers it. The habit that follows is to read every certificate shown on a product page rather than only the one that is a clickable link, because the fuller testing is often sitting there as images while the linked PDF is the older, thinner document. Whether the newer panel covers the vial you are about to buy is a question only the seller can close.

The storefront checks that still earn their place

Documents are the primary evidence, but four storefront properties are worth scoring because each one changes what happens when something goes wrong.

• A named laboratory. The Selank certificate names MZ Biolabs of Tucson, Arizona and the analyst who signed it; the Semax report names Kovera Labs and carries a report number and an access code for verification. A named laboratory can be contacted. An unnamed one is a logo.
• Domestic dispatch. A seller holding stock in the country of delivery can tell you the lot number before the parcel leaves, which is the only moment the lot question can be answered in advance. It also removes a customs step, and a customs step is where a lot trail most often goes cold.
• A written refund and replacement path. Not because a refund fixes a bad vial, but because a seller that will not put terms in writing has told you how a dispute will go.
• No human-use claims. A research supplier that starts recommending routes, schedules or outcomes has stepped outside the category it sells in, and a seller willing to be wrong about that is a seller willing to be wrong about other things.

What a perfect certificate would still not tell you

It is worth separating two questions that this market constantly merges. The six tests grade whether a supplier can demonstrate what is in a vial. They say nothing at all about whether the compound does anything useful, and a supplier scoring six out of six would move that second question by exactly zero.

On the second question, the published record is thinner than the marketing suggests. Selank was developed at the Institute of Molecular Genetics in Russia and holds a Russian registration as an anxiolytic; that is a national registration decision, not an FDA approval, and it is not evidence of efficacy by the standards used in this hub. The peer-reviewed literature that can be read in English is largely animal and cell work, such as the 2014 study in Molecular Immunology tracking inflammation-related gene expression under the tuftsin analogue. A search of ClinicalTrials.gov returns no registered study with Selank as an intervention. Keeping a national registration decision and a body of rodent data in separate columns is load-bearing here rather than pedantic, because the two are routinely presented to buyers as though they were one thing.

If you want the criteria above turned into a numeric rubric with the weights fixed in advance, our weighted scoring method for Selank suppliers publishes the scoring rule first and then applies it, including to the vendor advertised on this page.